MSH|^~\&#|CDC PRIME - Atlanta, Georgia (Dekalb)^2.16.840.1.114222.4.1.237821^ISO|COCAA|CO-ELR|CO|20280808092805-0600||ORU^R01^ORU_R01|MT_COCAA_ORU_AAPHELR.1.6214638|P|2.5.1|||||USA|UNICODE UTF-8|||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|MEDITECH, Inc.^L^^^^MEDITECH&1.3.6.1.4.1.24310&ISO^XX^^^MEDITECH|5.67|Laboratory Applicati|20210810||20210810
PID|1||100001^^^MEDITECH&2.16.840.1.114222.4.3.2.2.1.321.111&ISO^MR^COCAA~285-64-4175^^^MEDITECH&2.16.840.1.114222.4.3.2.2.1.321.111&ISO^SS^COCAA~X605236^^^MEDITECH&2.16.840.1.114222.4.3.2.2.1.321.111&ISO^PI^COCAA~E40014904640^^^MEDITECH&2.16.840.1.114222.4.3.2.2.1.321.111&ISO^AN^COCAA||BIERLY^LONNIE^^^^^L||19361023|M||2106-3^White^HL70005^W^White^L^2.5.1|4673 ELM ST^CHERRY CRK NURSING CTR^CAPITAN^NM^80014^USA^H||^PRN^PH^^1^303^6930111^^^^^+1 303 693 0111|^WPN^PH^^1^303^9999999^^Business^^^+1 303 999 9999||S|NOE^Nonreligious^HL70006|||||N^Not Hispanic or Latino^HL70189^2^Not Hispanic or Latin^L^2.9||||||||N|||20210809085200-0600|COCAA|337915000^Homo sapiens (organism)^SCT^Human^Human^L
NTE|1|P|EH|RE^Remark^HL70364^C^Comment^L
NK1|1|SURYAN^GENARO^^^^^L|OTH^Other^HL70063^OT^OTHER RELATIONSHIP^L|4861 20TH AVE^^THUNDER MOUNTAIN^NV^99999^USA^H|^PRN^PH^^1^720^3013954^^^^^+1 720 301 3954||||||||||||||||||||||||||^WPN^PH^^1^720^3013954^^^^^+1 720 301 3954|4861 20TH AVE^^AURORA^CO^99999^USA^H
PV1|1|I|E.ICUB^E.ICB^05|E|||1437205069^Hunt^James^Madison^MD^^^^Medical Center of Au&2.16.840.1.114222.4.1.144&ISO^^^^NPI|1437205069^Hunt^James^Madison^MD^^^^Medical Center of Au&2.16.840.1.114222.4.1.144&ISO^^^^NPI|1437205069^Hunt^James^Madison^MD^^^^Medical Center of Au&2.16.840.1.114222.4.1.144&ISO^^^^NPI~1962467126^Neid^James^M^MD^^^^Medical Center of Au^^^^NPI~1184669806^Hultman^Todd^^NP^^^^Medical Center of Au^^^^NPI|ICU||||PR|||1437205069^Hunt^James^Madison^MD^^^^Medical Center of Au&2.16.840.1.114222.4.1.144&ISO^^^^NPI|IN||01||||||||||||||||SAP|||COCAA||AD|||20280802055600+0000
OBR|1||21:AA:B0029251S.4^M12776123.4|50545-3^Bacterial susceptibility panel by Minimum inhibitory concentration (MIC)^LN^MDAPTOE^MIC DAPTOMYCIN E TEST^L|||20280807163601-0600|20280807163601-0600|||||SEPTIC SHOCK|||1871759365^Willison^Christopher^Beau^MD^^^^NPI&2.16.840.1.114222.4.1.144&ISO^L^^^NPI^RML|^WPN^PH^^1^303^4362727^^Hospital Line^^^+1 303 436 2727|21:AA:B0029251Sm12776123|09339017||TMCA, SOUTH CAMPUS|20210810062500-0600|||P|600-7&&LN&BCEXT&EXTENDED BLOOD CULTURE&L^1^ENTRAFVRE|||^21:AA:B0029251Sm12776123&RML||R6521^SEVERE SEPSIS WITH SEPTIC SHOCK^I10^R6521^SEVERE SEPSIS WITH SEPTIC SHOCK^I10
OBX|1|SN|35788-9^DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^DAP^DAPTOMYCIN^L|1|=^0.5|ug/mL^MicroGrams Per MilliLiter [Mass Concentration Units]^UCUM^ug/mL^ug/mL^L||S^Susceptible^HL70078|||P|||20280807163601-0600|MCOE^ROSE MEDICAL CENTER (MCOE)^LB||||20280807163601-0600||||ROSE MEDICAL CENTER (MCOE)^L|4567 E. NINTH AVENUE^^DENVER^CO^80220^USA^B^^S|1033122247^Chahal^Shalini^^MD^Dr.^^^RML^L^^^FI^ROSE MEDICAL CENTER
OBR|2||21:AA:B0029251S.5^M12776123.5|VGP-75^VITEK2 AST-GP75^L|||20280807163601-0600|20280807163601-0600|||||SEPTIC SHOCK|||1871759365^Willison^Christopher^Beau^MD^^^^NPI&2.16.840.1.114222.4.1.144&ISO^L^^^NPI^RML|^WPN^PH^^1^303^4362727^^Hospital Line^^^+1 303 436 2727|21:AA:B0029251Sm12776123|09339017||ROSE MEDICAL CENTER (MCOE)|20210810062500-0600|||P|600-7&&LN&BCEXT&EXTENDED BLOOD CULTURE&L^1^ENTRAFVRE|||^21:AA:B0029251Sm12776123&RML||R6521^SEVERE SEPSIS WITH SEPTIC SHOCK^I10^R6521^SEVERE SEPSIS WITH SEPTIC SHOCK^I10
OBX|1|CE|11011-4^Hepatitis Cvirus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection^LN^HCVRNA ^HEPATITIS C RNA QUANT^L||<^15 NOT DETECTED|IU/mL^IU/mL^L|NOT DETECTED||||F|||20191021035600-0600|QDI^QUEST DIAGNOSTICS ACC#70402353^LB
OBX|2|CE|38180-6^Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection^LN^HCVLOG^HEPATITIS C RNA PCR LOG^L||<^1.18 NOT DETECTED ||NOT DETECTED|H^High^HL70078|||F|||20191101090000-0700|QDI^QUEST DIAGNOSTICS ACC#70402353^LB
OBX|3|SN|29254-0^Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^LZD^LINEZOLID^L|1|=^2|ug/mL^MicroGrams Per MilliLiter [Mass Concentration Units]^UCUM^ug/mL^ug/mL^L||S^Susceptible^HL70078|||P|||20280807163601-0600|MCOE^ROSE MEDICAL CENTER (MCOE)^LB||||20280807163601-0600||||ROSE MEDICAL CENTER (MCOE)^L|4567 E. NINTH AVENUE^^DENVER^CO^80220^USA^B^^S|1033122247^Chahal^Shalini^^MD^Dr.^^^RML^L^^^FI^ROSE MEDICAL CENTER
OBX|4|ST|6933-6^Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^STS^STREPTOMYCIN SYNERGY SCREEN^L|1|SYN-S|ug/mL^MicroGrams Per MilliLiter [Mass Concentration Units]^UCUM^ug/mL^ug/mL^L||S^Susceptible^HL70078|||P|||20280807163601-0600|MCOE^ROSE MEDICAL CENTER (MCOE)^LB||||20280807163601-0600||||ROSE MEDICAL CENTER (MCOE)^L|4567 E. NINTH AVENUE^^DENVER^CO^80220^USA^B^^S|1033122247^Chahal^Shalini^^MD^Dr.^^^RML^L^^^FI^ROSE MEDICAL CENTER
OBX|5|SN|19000-9^Vancomycin [Susceptibility]^LN^VA^VANCOMYCIN^L|1|>=^32|ug/mL^MicroGrams Per MilliLiter [Mass Concentration Units]^UCUM^ug/mL^ug/mL^L||R^Resistant^HL70078|||P|||20280807163601-0600|MCOE^ROSE MEDICAL CENTER (MCOE)^LB||||20280807163601-0600||||ROSE MEDICAL CENTER (MCOE)^L|4567 E. NINTH AVENUE^^DENVER^CO^80220^USA^B^^R|1033122247^Chahal^Shalini^^MD^Dr.^^^RML^L^^^FI^ROSE MEDICAL CENTER
SPM|1|09339017^M12776123||119303007^Microbial isolate^SCT^ISLT^ISOLATE^L^07/31/2012^5.67||||||||||RA|||20280808092805-0600^20280808092805-0600|20210804001800-0600||||||||3.0|^BACTEC BLOOD CULTURE BOTTLES
